glp 1 glucagon dual receptor agonist GIP/GLP-1 agonists: New advances for treating type-2 diabetes Polyagonists Enable Increasingly Effective Treatment
Description
Although past meta-analyses reported substantial reductions in MACE with DPP-4 inhibitors [23], their conclusions were based on studies with small sample sizes and limited numbers of cardiovascular events, which have not been confirmed by the four CVOTs specifically designed to assess the CV safety of DPP-4 inhibitors
Diabete Metab 2008
the GLP-1 receptor agonist is injectable
doi: 10.1210/endocr/bqae155 24 HalimMADegerbladMSundbomMKarlbomUHolstJJWebbDLet al
PMID: 34497589
How to Get a GLP-1 Medication in Canada All GLP-1 medications in Canada are prescription-only
